CD28 Costimulation: From Mechanism to Therapy

Jonathan H. Esensten(University of California, San Francisco), Ynes Helou(University of California, San Francisco), Gaurav Chopra(Purdue University West Lafayette), Arthur Weiss(Howard Hughes Medical Institute), Jeffrey A. Bluestone(University of California, San Francisco)
Immunity
May 1, 2016
10.1016/j.immuni.2016.04.020
Cited by 940Open Access
Full Text

Abstract

Related Papers

The B7–CD28 superfamily
Arlene H. Sharpe, Gordon J. Freeman|Nature reviews. Immunology|2002|1.7k
CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells
Marc K. Jenkins, Patricia Taylor, Steven D. Norton et al.|The Journal of Immunology|1991|563
CD8+ CD28− and CD8+ CD57+ T cells and their role in health and disease
Marius Strioga, Vita Pašukonienė, Dainius Characiejus|Immunology|2011|508
Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
Flavio Vincenti, Christian P. Larsen, Josefina Alberú et al.|American Journal of Transplantation|2011|308
A point mutation in CD28 distinguishes proliferative signals from survival signals
Klaus Okkenhaug, Linda Wu, Kristine M. Garza et al.|Nature Immunology|2001|204